This is illustrated by a study to validate two candidates, RARB (retinoic acid receptor beta) and STMN2 (Stathmin-like 2), originally identified as part of a vCJD GWAS [7,31••]. Here, RARB is linked to variant Creutzfeldt-Jakob disease.